Crossmark Global Holdings, Inc. Lannett CO Inc Transaction History

Crossmark Global Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$4.17 - $5.74 $65,385 - $90,003	-15,680 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$5.75 - $7.13 $75,037 - $93,046	-13,050 Reduced 45.42%	15,680 $102,000
Q2 2020 Aug 14, 2020	BUY	$6.43 - $9.86 $38,580 - $59,160	6,000 Added 26.4%	28,730 $209,000
Q3 2019 Oct 09, 2019	SELL	$5.58 - $14.47 $502 - $1,302	-90 Reduced 0.39%	22,730 $255,000
Q2 2019 Jul 09, 2019	BUY	$5.22 - $9.08 $9,291 - $16,162	1,780 Added 8.46%	22,820 $138,000
Q1 2019 May 02, 2019	SELL	$5.35 - $9.82 $53 - $98	-10 Reduced 0.05%	21,040 $166,000
Q4 2018 Jan 31, 2019	BUY	$3.43 - $6.19 $72,201 - $130,299	21,050 New	21,050 $104,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.